Bile salt hydrolase (BSH) is a gut-bacterial enzyme that negatively influences host fat digestion and energy harvesting. The BSH enzyme activity functions as a gateway reaction in the small intestine by the deconjugation of glycineconjugated or taurine-conjugated bile acids. Extensive gut-microbiota studies have suggested that BSH is a key mechanistic microbiome target for the development of novel non-antibiotic food additives to improve animal feed production and for the design of new measures to control obesity in humans. However, research on BSH is still in its infancy, particularly in terms of the structural basis of BSH function, which has hampered the development of BSHbased strategies for improving human and animal health. As an initial step towards the structure-function analysis of BSH, C-terminally His-tagged BSH from Lactobacillus salivarius NRRL B-30514 was crystallized in this study. The 1.90 Å resolution crystal structure of L. salivarius BSH was determined by molecular replacement using the structure of Clostridium perfringens BSH as a starting model. It revealed this BSH to be a member of the N-terminal nucleophile hydrolase superfamily. Crystals of apo BSH belonged to space group P2 1 2 1 2, with unit-cell parameters a = 90.79, b = 87.35, c = 86.76 Å (PDB entry 5hke). Two BSH molecules packed perfectly as a dimer in one asymmetric unit. Comparative structural analysis of L. salivarius BSH also identified potential residues that contribute to catalysis and substrate specificity.
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Introduction
Microbiota residing in the intestine affect host physiology and growth performance via food digestion, nutrient utilization and host immunity modulation. Recent studies have indicated that gut microbiota are implicated in host energy regulation and the development of obesity in humans; thus, manipulating specific gut microbial functions may be one means to control obesity and its associated chronic diseases (DiBaise et al., 2008; Tilg et al., 2009) . The intestinal bile salt hydrolase (BSH), an enzyme produced by diverse gut microflora, catalyzes the essential gateway reaction in the metabolism of bile acids in the small intestine and plays an important role in host metabolism and energy harvesting (Begley et al., 2006; Jones et al., 2008; Martoni et al., 2015) . Using a controlled system, Joyce, MacSharry et al. (2014) recently obtained direct evidence demonstrating that BSH activity alone can significantly influence host lipid metabolism and weight gain. Consistent with the findings from this research in humans and mice, extensive research using food animals has shown that the growth-promoting effect of antibiotic growth ISSN 2053-230X # 2016 International Union of Crystallography promoters (AGPs) is highly correlated with decreased BSH activity as well as a significantly reduced population of Lactobacillus species, which are the major BSH producers in the intestine (Lin, 2014) . Thus, BSH inhibitors have been proposed as promising feed additives to replace AGPs in order to enhance food safety and the productivity of food animals (Lin, 2014; Wang et al., 2012) . Together, these recent findings have strongly suggested that BSH is a key mechanistic microbiome target for the development of novel alternatives to AGPs to enhance animal production and of new measures to control obesity in humans.
The BSH enzyme catalyzes the deconjugation of glycineconjugated or taurine-conjugated bile acids, which is an essential gateway reaction in the metabolism of bile acids in the small intestine (Begley et al., 2006) . The bile acids have dual digestive and signalling roles in the host; therefore, it has increasingly been recognized that intestinal BSH activity has a significant impact on host physiology by disturbing conjugated bile acid-mediated fat metabolism and endocrine functions (Begley et al., 2006; Jones et al., 2008; Martoni et al., 2015) . A number of BSH enzymes have been identified from different commensal bacteria, and Lactobacillus populations are the major BSH producers in the intestine. Despite recent significant progress in the characterization of diverse BSH enzymes, research on BSH is still in its infancy, particularly in terms of the structural basis of BSH function (Begley et al., 2006; Patel et al., 2010) . To date, crystal structures of BSH enzymes from only two specific species, Bifidobacterium longum and Clostridium perfrigens, have been reported (Kumar et al., 2006; Rossocha et al., 2005) . Given the ecological diversity of BSH in the gut microbiome, structural analyses of BSH enzymes from various species are warranted, and would lead to the discovery of the critical residues in catalysis and provide key information on the substrate selectivity of BSH enzymes (Begley et al., 2006) . Clearly, structural studies on BSH will also directly facilitate future translational research, such as the use of molecular docking to develop BSH inhibitor-based alternatives to AGPs for growth promotion in food animals (Lin, 2014) .
Recently, we have identified and characterized a BSH enzyme from L. salivarius NRRL B-30514 (Wang et al., 2012) . L. salivarius BSH (lsBSH) was able to efficiently hydrolyze both glycoconjugated and tauroconjugated bile salts. Thus, unlike many BSH enzymes from other bacteria, which have a narrow substrate spectrum, this BSH displayed potent hydrolytic activity towards a broad range of substrates (Wang et al., 2012) . The broad substrate specificity of lsBSH makes it an ideal candidate for structure-function analysis and for the identification of desired BSH inhibitors using computational techniques. Here, we report the crystallization, X-ray diffraction analysis and structure of lsBSH.
Materials and methods

Macromolecule production
Recombinant lsBSH was produced in Escherichia coli using the pET-21b vector (Novagen). The cloning and purification were described in a recent publication (Wang et al., 2012) . The key information for lsBSH production is briefly summarized in Table 1 . Recombinant lsBSH protein, containing a 6ÂHis tag at the C-terminus, was overproduced in E. coli BL21 (DE3) cells and subsequently purified using a modified procedure. Briefly, the E. coli cells were grown in LB medium containing 100 mg ml À1 ampicillin at 37 C until the OD 600 reached 0.6-0.8. Expression of lsBSH was induced by the addition of isopropyl -d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. The growth temperature was decreased to 15 C after induction and the culture was further grown for approximately 16 h. Subsequently, the cells were harvested by centrifugation at 5000g at 4 C for 20 min and the pellets were resuspended in lysis buffer consisting of 50 mM Tris-HCl pH 7.0, 500 mM NaCl, 5%(v/v) glycerol, 50 mM imidazole. The resuspended cells were then lysed using a Microfluidics high-pressure homogenizer and centrifuged at 18 000 rev min À1 for 1 h at 277 K. The supernatant was subjected to the following stepwise purification. Firstly, the supernatant was loaded onto an Ni-NTA column and washed with a buffer consisting of 50 mM Tris-HCl pH 7.0, 50 mM NaCl, 5%(v/v) glycerol, 50 mM imidazole. The His-tagged lsBSH was eluted with a buffer consisting of 50 mM Tris-HCl pH 7.0, 50 mM NaCl, 5%(v/v) glycerol, 150 mM imidazole. The purified lsBSH fractions from the Ni-NTA column were then subjected to Mono Q chromatography and eluted with a Table 1 Macromolecule-production information for lsBSH.
Source organism
L. salivarius NRRL B-30514 DNA source Genomic DNA Forward primer † gradient of sodium chloride [the buffer consisted of 50 mM Tris-HCl pH 7.0, 1 M NaCl, 5%(v/v) glycerol, 2 mM DTT with a 1-60% gradient of sodium chloride in 20 column volumes (CV)]. Subsequently, the pooled lsBSH fractions were further purified using hydrophobic interaction chromatography on a phenyl column; the column was washed with buffer consisting of 50 mM Tris pH 7.0, 0.5 M NaCl, 5% glycerol, 2 mM DTT, and lsBSH was eluted using a 10 CV gradient to a buffer consisting of 50 mM Tris-HCl pH 7.0, 5%(v/v) glycerol. Finally, the lsBSH fractions were pooled and concentrated to about 3 mg ml À1 for purification by Superdex 200 chromatography. lsBSH protein with high purity was eluted with buffer consisting of 10 mM sodium acetate pH 5.5, 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 10%(v/v) glycerol.
After purification, the purity of the lsBSH was judged using 12% SDS-PAGE as described previously (Wang et al., 2012) . The purified lsBSH was extensively dialysed against buffer consisting of 10 mM sodium acetate pH 5.5, 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 10%(v/v) glycerol and was then concentrated to 16.0 mg ml À1 for crystallization as described below.
Crystallization
Crystal screening was performed at 293 K by the sittingdrop vapour-diffusion method. 200 nl purified lsBSH at a final concentration of 16.0 mg ml À1 in buffer consisting of 10 mM sodium acetate pH 5.5, 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% glycerol was mixed with 200 nl reservoir solution and equilibrated against 15 ml reservoir solution using a Mosquito LCP (TTP Labtech). Commercial crystallization kits from Hampton Research and Qiagen were used for crystal screening. Initial crystals of lsBSH were obtained in a condition consisting of 0.2 M KH 2 PO 4 pH 4.8, 20%(w/v) polyethylene glycol 3350 and further optimization was carried out by micro-seeding under the same condition. Crystallization information is summarized in 
Data collection and processing
All crystals were flash-cooled with the addition of 25% glycerol as a cryoprotectant and diffraction data were collected at Biortus, Jiangyin, People's Republic of China with a home-source diffraction system consisting of a Rigaku F-RE ++ generator and a Saturn 944 CCD detector. The datacollection statistics are shown in Table 3 .
Structure solution and refinement
The structure of lsBSH was determined by the molecularreplacement method using Phaser (McCoy et al., 2007) with the C. perfringens BSH (cpBSH) structure as a search model (Rossocha et al., 2005 ; PDB entry 2bjf; 37% sequence identity). Structure refinement was performed with Coot (Emsley et al., 2010) and REFMAC5 (Murshudov et al., 2011) and is summarized in Table 4 .
Results and discussion
We have determined the 1.90 Å resolution crystal structure of lsBSH in space group P2 1 2 1 2 (PDB entry 5hke). It showed two lsBSH molecules packed perfectly as a dimer in the asymmetric unit (Fig. 1a) . The presence of the dimer in solution was confirmed by gel filtration with Superdex 200 (Fig. 1b) . Analysis of the protein interfaces with PISA showed that lsBSH can be stable as a tetramer and as a dimer in solution (Krissinel & Henrick, 2007) .
Except for residues 1 and 301-305, which are missing from the structure of lsBSH, all amino acids are well defined, including Cys2, which was oxidized to a cysteinesulfonic acid. The overall structure consisted of a four-layered core and showed an N-terminal nucleophile (Ntn) hydrolase-like fold, similar to the previously reported structures of C. perfrigens BSH (cpBSH), B. longum BSH (blBSH) and Lysinibacillus sphaericus penicillin V acylase (bsPVA) (Kumar et al., 2006; Rossocha et al., 2005; Suresh et al., 1999; Fig. 2) .
A superimposition of the structure of lsBSH with those of cpBSH and blBSH shows that they share the conserved catalytic active centre containing the cysteine nucleophile (Cys2) and its coordinated neighbouring amino acids (Kumar et al., 2006; Rossocha et al., 2005) . However, the amino acids surrounding the binding pocket are inconsistent (Fig. 3) . Differences were mainly observed in the amino acids within two loops: loop I consisting of amino acids 20-27 and loop II consisting of amino acids 125-139 (residue numbers from lsBSH; Fig. 3a ). Loop II of lsBSH is closer to the taurodeoxycholate than that in the cpBSH complex structure (PDB entry 2bjf). In loop II the hydrophobic residue Leu134 in lsBSH intrudes into the pocket and condenses the entrance to the substrate-binding pocket (Fig. 3b ). Phe130 may also contribute to this restrained spatial configuration (Fig. 3b) . In loop I, Tyr24 in lsBSH (corresponding to Phe26 in cpBSH), along with Phe65 (corresponding to Ala68 in cpBSH), also intrudes into the binding pocket (Fig. 3c) . These observations suggest that these amino acids may force the substrate to bind in a different orientation, such as that rotated by 90 , and to sit deeply in the binding pocket, which will lead to different enzyme-substrate interactions and is obviously different from what was observed in cpBSH (Rossocha et al., 2005) . In blBSH, which exhibits a preference for glycoconjugated bile salts over tauroconjugated bile salts (Kumar et al., 2006) , Tyr24 is present in loop I as observed in lsBSH; however, the large hydrophobic amino acid Trp21 (corresponding to Leu20 in lsBSH and Ile22 in cpBSH) seems to make this tyrosine point outwards from the binding pocket (Fig. 3c ). In addition to the differences observed in these two loops as described above, comparison of lsBSH with cpBSH and blBSH also identified differences in other surrounding amino acids in lsBSH, Structural superimposition of lsBSH (yellow; PDB entry 5hke) with cpBSH (cyan; PDB entry 2bjf), blBSH (grey; PDB entry 2hf0) and L. sphaericus penicillin V acylase (slate; PDB entry 3pva). Table 5 Major amino-acid residues of lsBSH that are potentially involved in catalysis and substrate specificity based on comparative structural analysis.
Residue Specific location Speculation Tyr24
Loop I Along with Phe65, may force the substrate to sit deeply in the binding pocket Leu18
Loop I Given their differences when compared with the structures of cpBSH and blBSH, they may contribute to different enzyme-substrate interactions Phe22
Loop I Leu134
Loop II Both residues contribute to restraint of the spatial configuration by condensing the substrate-binding pocket entrance Phe130
Loop II Ile56
Bottom of the binding pocket Compared with the structures of cpBSH and blBSH, these two residues may determine the differing substrate specificities Leu63
Bottom of the binding pocket Phe65
Bottom of the binding pocker Along with Tyr24, may force the substrate to sit deeply in the binding pocket in blBSH) and Ile56 (corresponding to Thr59 in cpBSH and Val58 in blBSH) located at the bottom of the binding pocket, and Phe22 (corresponding to Tyr24 in cpBSH and Phe23 in blBSH) and Leu18 (corresponding to Met20 in cpBSH and Leu19 in blBSH) located in loop I (Fig. 3c ). These differences may also contribute to the different enzyme-substrate interactions, consequently determining the different substrate specificities. Together, unlike the binding pocket in cpBSH that shows an open entrance with a shallow bottom, a number of unique residues in lsBSH make lsBSH display a narrow entrance to the binding pocket and an increased inner capacity of the binding pocket, which may enable the substrate to sit deeply in the pocket with a different conformation and lead to the different enzyme-substrate interaction (broad spectrum of specificity); these residues are summarized in Table 5 . Previous comparative genomics and structural studies have identified several conserved, catalytically important residues in the active site of BSH (Cys2, Arg16, Asp19, Asn79, Asn171 and Arg224); however, this conclusion was primarily based on comparison of the structure of BSH with that of penicillin V acylase (Begley et al., 2006; Kumar et al., 2006; Wang et al., 2012) . To date, Cys2 is the only residue that has been subjected to site-directed mutagenesis and validated for its essential role in the activity of BSH (Kumar et al., 2006) . Therefore, future in-depth structural analysis of lsBSH (e.g. in complex with a specific substrate) in conjunction with comprehensive amino- acid substitution mutagenesis would help us to discover the critical residues in catalysis and to understand why lsBSH displays a potent catalytic activity towards a broad spectrum of substrates including both glycoconjugated and tauroconjugated bile salts.
